For the press

Latest

    1. Computational and Systems Biology
    2. Cancer Biology

    New computational tool could improve discovery of cancer treatments

    Scientists have developed retriever, a computational tool that extracts disease-specific drug response signatures to predict the best combinations for cancer treatment.
    1. Developmental Biology

    Cell polarity coordinates jellyfish larval development along a central axis

    Researchers have discovered that a single molecule, Wnt3, coordinates a two-step process of cell polarity orientation that enables jellyfish embryos to develop around a central axis, shedding light on how the body plans of early animals evolved.
    1. Cancer Biology

    Sustained inhibitor treatment shows promise for drug-resistant breast cancer

    Maintaining treatment with CDK4/6 inhibitors significantly suppresses the growth of breast cancer cells, even after drug resistance has developed, according to new research.
    1. Biochemistry and Chemical Biology

    Study suggests stalled amyloid protein production drives Alzheimer’s disease

    A study of rare familial genetic mutations linked to early-onset dementia supports the idea that stalled protein processing contributes to Alzheimer’s disease.
  1. eLife appoints Timothy Behrens as Editor-in-Chief

    Behrens will lead eLife’s efforts to improve research communication for all.
  2. Media Coverage: December roundup of eLife papers in the news

    High-profile news coverage that eLife papers generated in December 2024, including Asia Research News, The New York Times and La Gaceta.
    1. Plant Biology

    Parasite ‘matchmakers’ genetically alter plant cells to attract insects

    Researchers have revealed how parasitic phytoplasmas manipulate plant biology to act as matchmakers, boosting male insect appeal by modulating hosts to attract more reproductive females.
    1. Genetics and Genomics

    Gene discovery sheds light on common ear condition in people with Down syndrome

    The gene DYRK1A could be a potential therapeutic target to treat ‘glue ear’ in people with Down syndrome, according to a new study.
  3. Media Coverage: November roundup of eLife papers in the news

    High-profile news coverage that eLife papers generated in November 2024, including Asia Research News, LiveScience and Earth.com.
  4. Media Coverage: October roundup of eLife papers in the news

    High-profile news coverage that eLife papers generated in October 2024, including Earth.com, StudyFinds and Cosmos Magazine.

Enquiries about published papers, material in press and eLife may be directed to press@elifesciences.org, or +44 1223 855373.

If you’re writing about an eLife study, please cite eLife as the source of the article and include a link to either the article or elifesciences.org, preferably using our DOI: https://doi.org/10.7554/eLife – with the article’s five-digit extension (e.g. https://doi.org/10.7554/eLife.00000). Reviewed Preprints follow the same format, but with the latest article version number added at the end (e.g. https://doi.org/10.7554/eLife.00000.1). Thank you!

All content, unless otherwise stated, is available under a Creative Commons Attribution License (CC-BY). All are free to use and reuse the content provided the original source and authors are credited.

The eLife media policy encourages authors to share and discuss their preprints at any time and indicates that we do not release content under embargo.

Please don’t hesitate to contact us if you have any questions.